Počet záznamov: 1
vakcíny konjugované
SYS d018074 LBL 00000cz--a2200000n--4500 005 20250606214006.8 008 930604|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D20.215.894.865.900 065 $a D23.050.865.900 066 $a 01 $c 03 150 $a vakcíny konjugované $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x MI $x PD $x PO $x RE $x ST $x TO $x TU $x UL $x UR $x VI $2 slo 450 $w v $a Conjugate Vaccine $2 eng 450 $w v $a vakcína konjugovaná $2 slo 665 $a 94 $2 eng 665 $a vaccine components/immunology (1984-1993) $2 eng 665 $a Vaccines, Synthetic (1988-1993) $2 eng 680 9-
$i Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. $2 eng 680 $a "induce antibody formation in people not responsive to polysaccharide alone"; semisynthetic vaccines; coord NIM with specific vaccine (IM) $2 eng 750 -2
$a Vaccines, Conjugate $2 eng 980 $x M
Počet záznamov: 1